HIGHLIGHTS
- who: Nicola Landi et al. from the Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania u2018Luigi Vanvitelli`, Via Vivaldi, Caserta, Italy have published the paper: A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells, in the Journal: Toxins 2023, 15, 57. of /2023/
- what: The aim of this study was to improve cetuximab`s therapeutic action by conjugating with the type 1 ribosome inactivating protein (RIP) quinoin isolated from quinoa seeds. chemical conjugation strategy the use of heterobifunctional . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.